CRABP1 and neurodegenerative disease: Importantly, in human studies, drastically reduced Crabp1 gene expression has been reported in neurodegenerative disease patients, including ALS and SMA patients [48,49]; therefore, we prioritized the studies of CRABP1-binding ligands in the context of MN degeneration.